Spartan Capital Annual Investor Conference
heltzeninvestor
CEO of eXoZymes to Present at Spartan Capital Securities’ Second Annual Investor ConferenceOctober 29, 2025
CEO of eXoZymes to Present at ThinkEquity’s Annual Investor Conference
heltzeninvestor
CEO of eXoZymes to Present at ThinkEquity’s Annual Investor ConferenceOctober 23, 2025
Lightning Rx, Colette Nataf
press clippingspodcast
Podcast: Lightning Rx' Colette Nataf interviews CEO Heltzen on future of biomanufacturingOctober 22, 2025
Podcast: 'The Catalyst' interviews CEO, Michael Heltzen
heltzenpress clippingsvideopodcast
Podcast: 'The Catalyst' interviews CEO, Michael HeltzenOctober 17, 2025
Zachary Karl, Vice President Business Development @ Bio Innovations Midwest 2025
press clippingsvideo
World Bio Markets: AI - A tool U.S. industrial biomanufacturing cannot ignoreOctober 8, 2025
Inside Biotech podcast interviews CEO, Michael Heltzen
heltzenpress clippingsvideopodcast
Podcast: 'Inside Biotech' interviews CEO, Michael HeltzenOctober 2, 2025
CCO Damien Perriman and co-founder and VP of Development, Dr. Paul Opgenorth.
press releasescienceperriman
Driving the cell-free revolution: eXoZymes leaders join BioMADE Leadership & Technical CommitteesSeptember 30, 2025
MDB Capital: eXoZymes & NCTx: The Breakthrough Opportunity with NCTx and Treating a Global Health Epidemic
heltzeninvestorpress clippingsvideo
MDB Capital: eXoZymes & NCTx: The Breakthrough Opportunity with NCTx and Treating a Global Health EpidemicSeptember 18, 2025
The challenges of SynBio
video
The challenges of SynBioSeptember 15, 2025
Transcript: Q2 2025 Earnings Call
investorvideo
Transcript: Q2 2025 Earnings CallAugust 13, 2025
Previous page
Page 5 of 12
Next page